Tepmetko

FDA Approves Merck KGaA's Tepmetko for Aggressive Lung Cancer
BioSpace
Wed, 02/3/21 - 11:04 pm
Merck KGaA
Tepmetko
FDA
metastatic non-small cell lung cancer